Overexpression of metallothionein confers resistance to anticancer drugs

Science

Volumn 241, Issue 4874, 1988, Pages 1813-1815

  Kelley, Susan L ^a   Basu, Alakananda ^b   Teicher, Beverly A ^c   Hacker, Miles P ^d   Hamer, Dean H ^e   Lazo, John S ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MELPHALAN; METALLOTHIONEIN; VINCRISTINE;

ANIMAL CELL; CANCER; CELL CULTURE; DRUG RESISTANCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; CELLS, CULTURED; DRUG RESISTANCE; IN VITRO; METALLOTHIONEIN; MICE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023696141     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.3175622     Document Type: Article

References (0)